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When exposed to proteotoxic environmental condi-
tions, mammalian cells activate the cytosolic stress
response in order to restore protein homeostasis. A
key feature of this response is the heat shock tran-
scription factor 1 (HSF1)-dependent expression of
molecular chaperones. Here, we describe the results
of an RNA interference screen in HeLa cells to iden-
tify modulators of stress response induction and
attenuation. The modulator proteins are localized in
multiple cellular compartments, with chromatinmod-
ifiers and nuclear protein quality control playing a
central regulatory role. We find that the acetyltrans-
ferase, EP300, controls the cellular level of activat-
able HSF1. This involves acetylation of HSF1 at
multiple lysines not required for function and results
in stabilization of HSF1 against proteasomal turn-
over. Acetylation of functionally critical lysines during
stress serves to fine-tune HSF1 activation. Finally,
the nuclear proteasome system functions in attenu-
ating the stress response by degrading activated
HSF1 in a manner linked with the clearance of mis-
folded proteins.
INTRODUCTION
The cytosolic stress response, generally known as the heat
shock response (HSR), is one of the primary defense mecha-
nisms activated by cells to maintain protein homeostasis (pro-
teostasis) when exposed to proteotoxic conditions (Anckar and
Sistonen, 2011; Gidalevitz et al., 2011; Neef et al., 2011). The
eukaryotic HSR is highly conserved and results in the increased
production of heat shock proteins (HSPs)—mainly molecular
chaperones and proteases that prevent the aggregation of mis-
folded proteins and mediate their refolding or degradation (Fryd-
man, 2001; Hartl et al., 2011; Richter et al., 2010). Activation ofthe HSR can be autonomously triggered by protein damage
occurring in isolated cells due to adverse external conditions,
such as exposure to elevated temperature or protein denaturing
agents, or when cells express proteins that are unable to fold
due to mutation or incorporation of amino acid analogs. In
metazoans, stress response pathways, including the HSR, are
also subject to cell-non-autonomous and tissue selective
control, apparently bymechanisms of endocrine communication
between tissues and organs (Durieux et al., 2011; Guisbert et al.,
2013; Prahlad et al., 2008; van Oosten-Hawle et al., 2013).
Induction of the HSR is mediated by heat shock transcription
factors (HSFs). Four distinct but related HSFs are known in
vertebrates (HSF1 to HSF4) (Anckar and Sistonen, 2011), with
HSF1 being the master regulator. Besides controlling the
expression of HSPs, HSF1 also regulates transcriptional
programs supporting cell survival and tumorigenesis (Mendillo
et al., 2012; Santagata et al., 2013). Human HSF1 is an
57 kDa protein consisting of a N-terminal DNA-binding domain,
a bipartite heptad repeat oligomerization domain, a regulatory
domain, and a C-terminal transactivation domain (Anckar and
Sistonen, 2011; Neef et al., 2011). Stress-dependent transcrip-
tional regulation by HSF1 is a multistep process that is only
partially understood. Inactive HSF1 monomers are predomi-
nantly located in the nucleus due to a potent bipartite nuclear
localization signal, but HSF1 shuttling between the nucleus
and cytosol has been reported. Thermal stress inhibits HSF1
export, leading to further nuclear accumulation (Anckar and
Sistonen, 2011; Mercier et al., 1999). Monomeric HSF1 is stabi-
lized by binding to chaperones, including Hsp70, Hsp90, and
their cofactors. Activation requires dissociation from these chap-
erones, generally due to displacement by misfolded proteins
accumulating under stress (Morimoto, 2002; Shi et al., 1998;
Zou et al., 1998). Free HSF1 then trimerizes and acquires
competence for binding to heat shock elements in the promoter
regions of target genes (Anckar and Sistonen, 2011; Pelham,
1982). Complex posttranslational modifications are additionally
involved in rendering HSF1 transactivation competent by mech-
anisms that are not well understood. Oligomerization is accom-
panied by phosphorylation of multiple serine residues in theCell 156, 975–985, February 27, 2014 ª2014 Elsevier Inc. 975
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Figure 1. Design of Genome-Scale RNAi
Screen for Modulators of HSR
(A) HS-inducible HSPA1A-Fluc and constitutive
CMV-Rluc constructs in iFluc-Rluc cells. Reporter
activities expected under normal and HS condi-
tions are shown schematically.
(B) Time course of Fluc:Rluc activity ratios and cell
viability measured by MTT assay in reporter cells
upon exposure to HS (43C). Reporter activities
were measured after 2 hr recovery at 37C. Similar
Fluc:Rluc ratios were measured after 4 hr of
recovery. SDs are from at least three independent
experiments.
(C) Fluc:Rluc activity ratios after RNAi treatment.
Reporter cells were either not transfected, trans-
fected with control esiRNA targeting EGFP, or
transfected with esiRNA targeting HSF1. After
68 hr, cells were exposed to HS for 2 hr at 43C
followed by 2 hr recovery at 37C (+HS) or main-
tained at 37C (HS). SDs are from at least three
independent experiments.
(D) mRNA levels of HSF1, HSPA1A (Hsp70), Fluc,
Rluc, and GAPDH after transfection with esiRNAs
as indicated. After 70 hr, cells were exposed to HS
for 2 hr at 43C, and mRNA levels were analyzed
by RT-PCR directly after HS. Representative
results from at least three independent experi-
ments are shown.
See also Figure S1.regulatory domain (Batista-Nascimento et al., 2011; Guettouche
et al., 2005). A phosphorylation-dependent sumoylation step is
thought to be involved in HSF1 repression (Hietakangas et al.,
2003). Furthermore, acetylation at lysine 80 in the DNA-binding
domain was shown to reduce the dwell time of HSF1 on DNA,
accelerating HSR attenuation (Westerheide et al., 2009).
Protein misfolding and aggregation are linked to numerous
pathological conditions, including neurodegeneration, type II
diabetes, and heart disease. The manifestation of many of these
diseases may be related to an age-dependent decline of cellular
proteostasis capacity (Ben-Zvi et al., 2009; Gupta et al., 2011;
Powers et al., 2009). Thus, boosting proteostasis by pharmaco-
logically activating the HSR may serve to mitigate these degen-
erative conditions (Calamini et al., 2012; Neef et al., 2011;
Powers et al., 2009). In contrast, tumor cells are generally more
dependent on chaperone capacity than untransformed cells
(Dai et al., 2007), due to the accumulation of destabilizing
mutations in key signaling proteins. Hence, inhibition of the
HSR is considered beneficial in cancer treatment. However, rela-
tively little is known about the cellular pathways that regulate the
HSR, and potential targets for its activation or inhibition remain to
be identified.
In order to elucidate the mechanism underlying the regulation
of the HSR, we have conducted a genome-scale RNAi screen in
HeLa cells. We find that the nuclear machineries involved in
chromatin modification and protein quality control have a central
role in regulating the induction and attenuation of the stress
response. In the absence of stress, the acetyltransferase,
EP300, controls the pool of activatable HSF1. This involves
stabilization of HSF1 by acetylation at multiple lysines. Additional
acetylation at functionally critical lysines during heat stress976 Cell 156, 975–985, February 27, 2014 ª2014 Elsevier Inc.dampens the HSR. As shown by proteomic analysis, the pro-
teasome system has an essential role in restoring the nuclear
proteome after stress. This function is coupled with attenuation
of the HSR through the degradation of HSF1.
RESULTS
RNAi Screen forModulators of theHeat ShockResponse
To conduct a genome-scale RNAi screen for modulators of the
HSR, we generated a HeLa reporter cell line, iFluc-Rluc,
expressing stress-inducible firefly luciferase (Fluc) under the
human HSPA1A (hsp70.1) promoter and the unrelated luciferase
of Renilla reniformis (Rluc) under the constitutive cytomegalo-
virus (CMV) promoter. HSF1 binds to the hsp70.1 promoter
upon stress and induces Fluc expression. The ratio of Fluc to
Rluc luminescence activities serves as a measure of HSR induc-
tion (Figure 1A). Fluc and Rluc are thermolabile enzymes (Gupta
et al., 2011) and are deactivated by heat treatment but regain
most of their specific activity within 10 min during recovery
(Figure S1A available online). Downregulation of positive or
negative modulators of the HSR by RNAi would reduce or
enhance the expression of Fluc, respectively.
Heat stress (HS) at 43C for 2 hr induced Fluc expression, and
the Fluc:Rluc activity ratio measured upon recovery at 37C
increased up to 50-fold (Figures 1B and S1B); longer HS expo-
sure resulted in partial attenuation of the HSR and reduced cell
viability (Figure 1B). To test the dependence of Fluc expression
on HSF1, iFluc-Rluc cells were transfected with an endoribonu-
clease-prepared short interfering RNA (esiRNA) (Kittler et al.,
2005) targeting HSF1 or with a control esiRNA against enhanced
green fluorescent protein (EGFP). 68 hr after transfection, cells
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Figure 2. Cellular Localization of HSR Modulators and Their
Involvement in Proteostasis
(A) HSR modulators are grouped according to primary cellular localization and
function. Positive modulators are shown in green, and negativemodulators are
shown in red.
(B) Effect of downregulation of HSR modulators on formation of FlucDM-GFP
inclusions upon HS. HEK293T cells stably expressing FlucDM-GFP were
transfected with control esiRNA targeting Rluc andOLFML3 (olfactomedin-like
3) or esiRNAs targeting HSR modulators categorized in (A): mito, mitochon-
drial; cyto, cytoplasmic; and PM, plasma membrane. 70 hr after transfection,
cells were exposed to HS (2 hr at 43C), and the percentage of cells with
FlucDM-GFP inclusions was quantified. OLFML3 downregulation had no
effect on Fluc:Rluc activity ratio in the primary screen (Table S1A) and served
as a negative control. SDs represent results from at least three different fields
of view (200 cells per view).
See also Figure S2 and Table S1.were either exposed to HS, followed by recovery at 37C, or
maintained at 37C (Figure 1C). EGFP esiRNA had no effect on
the induction of the stress response, as judged by the Fluc:Rluc
activity ratio (Figure 1C). The level of Fluc and HSPA1A mRNA,
measured immediately after HS, was increased, whereas Rluc
mRNA remained constant during HS and recovery (Figures 1D
and S1B). In contrast, the Fluc:Rluc activity ratio upon HS was
reduced >4-fold upon silencing of HSF1 (Figure 1C), which isconsistent with the loss of induction of Fluc and endogenous
HSPA1A mRNA during HS (Figure 1D).
The primary RNAi screen was performed by transfecting iFluc-
Rluc cells with individual esiRNAs targeting more than 15,000
human genes (Figure S1C and Extended Experimental Proce-
dures). A low stringency protocol was followed to minimize
false-negative results (Z score deviation – 2.5/+2 from average
for positive and negative modulators, respectively) (Figure S1D).
Using these criteria, esiRNAs targeting the transcripts of 705
genes caused a significant reduction in Fluc:Rluc activity ratio
upon HS, whereas esiRNAs targeting an additional 287 tran-
scripts enhanced the response (Figure S1C and Tables S1A
and S1B), suggesting a role for these genes as positive or
negative modulators of the HSR, respectively. To identify the
strongest HSR modulators, we repeated the screen for this set
of candidates in triplicate using more stringent criteria (Z score
deviation from average of ±3 in all 3 independent repeats). We
confirmed 116 positive and 54 negative modulators (Figures
S1C and S1E and Table S1C). A second round of validation
was then performedwith esiRNAs targeting independent regions
of these transcripts, which identified a final set of 55 positive and
14 negative modulators (Figures S1C and S1F and Tables S1D
and S1E).
Overview of HSR Modulators and Functional Validation
The screen revealed that regulation of the HSR relies on the
integration of signals generated in several cellular processes
and cell compartments (Figure 2A and Tables S1D and S1E).
Approximately 40% of the modulator proteins (24 positive and
2 negative) have their primary location in the nucleus. 17 modu-
lators (25%) are cytoplasmic (or cytoplasmic and nuclear), and
13 modulators are localized in organelles (mitochondria, endo-
plasmic reticulum, and lysosomes) or the plasma membrane.
Another 13 modulators are poorly characterized and include
proteins with predicted nuclear localization signals or transmem-
brane segments (Figure 2A and Tables S1D and S1E).
A central function of the HSR is to prevent protein aggregation
under cell stress. To verify that the positive HSR modulators
influence this process, we downregulated a representative set
of modulators in HEK293T cells stably expressing the proteo-
stasis sensor protein FlucDM-GFP (Gupta et al., 2011). This
reporter carries two destabilizingmutations in Fluc, which render
the protein aggregation sensitive. Silencing of the positive HSR
modulators strongly increased visible FlucDM-GFP inclusions
upon HS compared to cells transfected with control esiRNA
(Rluc or OLFML3) (Figures 2B and S2A). No significant increase
in aggregation was observed when the negative HSRmodulator,
DAP3, was downregulated (Figure 2B). Downregulation of
proteasome subunits did not suppress inclusion formation
(Figures 2B and S2A), presumably because proteasome inhibi-
tion prevents the clearance of misfolded FlucDM-GFP (Park
et al., 2013).
The nuclear HSR modulators include several subunits of
histone acetyltransferase complexes, such as EP300, CREB-
binding protein (CREBBP), and SRCAP, as well as four histone
methyltransferases (Figure 2A), underscoring the importance of
chromatin reorganization in heat shock gene transcription
(Petesch and Lis, 2008). Silencing of these modulators stronglyCell 156, 975–985, February 27, 2014 ª2014 Elsevier Inc. 977
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Figure 3. The Nuclear Network of HSR Modulators
The largest connected component of experimentally validated physical
interactions of the HSR modulators was analyzed based on interactions
retrieved from BioGRID. Positive and negative HSR modulators are shown as
green and red circles, respectively. Proteins forming network nodes interact-
ing with five or more HSR modulators are shown in blue. Other nodes, con-
necting less than five HSRmodulators, are shown as open circles. Interactions
between the HSR modulators identified in the RNAi screen are shown in
magenta. HSF1 is highlighted in yellow. Ubiquitin (UBC, P0CG48) with all its
interactions was omitted from the network for clarity.
See also Table S2.interfered with the induction of endogenous HSPA1A mRNA
during HS (Figure S2B). The identification of core components
of the mRNA splicing machinery as positive HSR modulators
was surprising, as splicing is generally inhibited during HS
(Biamonti and Caceres, 2009). We found that downregulation
of SF3B1, SMU1, and SNRPF lowered the mRNA and protein
level of HSF1 (Figure S2C), explaining the reduced activation of
the HSF1 reporter. The RNA transport proteins identified by
the screen are likely important for exporting newly synthesized978 Cell 156, 975–985, February 27, 2014 ª2014 Elsevier Inc.mRNAs to the cytoplasm under stress conditions. Comparatively
few positive modulators with diverse functions were identified
in the cytoplasm (Table S1D). Their association with the HSR
remains to be investigated.
The identification of several multipass membrane proteins as
positive HSR modulators is intriguing. These proteins include
putative cell surface receptors (SSTR1; TM7SF3; PAQR5) with
seven transmembrane helices that may function as G-protein-
coupled receptors and could play a role in stress sensing or
communicating stress status between cells. The modulators in
the cell membrane also include the KCND1 potassium channel,
which is consistent with a proposed role of potassium and
calcium channels in the HSR inmammalian and plant cells (Finka
et al., 2012; Saad and Hahn, 1992).
The absence of kinases and major chaperone components
among the identified HSR modulators is notable. Phosphoryla-
tion of HSF1 is considered critical for activation, but multiple
kinases have been reported to be involved (Anckar and Sistonen,
2011; Batista-Nascimento et al., 2011; Guettouche et al., 2005),
suggesting functional redundancy. Similarly, redundancy among
the chaperones participating in HSF1 activation may have
prevented their identification. Although subunits of the cytosolic
chaperonin TRiC/CCT and the Hsp70-Hsp90 organizing protein
Hop (STIP1) were identified as positive modulators, this may be
explained by the chaperone requirement of the Fluc reporter for
folding. Indeed, downregulation of these components did not
prevent the induction of HSPA1A mRNA upon HS (data not
shown).
Most of the negative HSR modulators are components of
the ubiquitin-proteasome system (UPS), including six subunits
of the 20S proteasome core complex, one subunit of the 19S
regulatory particle (PSMD11), and two other UPS components,
RBX1 and NPLOC4 (Figure 2A). The proteasome is localized to
the cytoplasm and nucleus (Russell et al., 1999). As shown
below, silencing of proteasomal subunits delayed the attenua-
tion of the HSR.
A Nuclear Protein Network Regulating the HSR
We used the BioGRID interaction database to explore whether
different HSR modulators interact within a network. 58 of the
69 HSR modulators have UniProt accessions. 43 of these (30
positive and 13 negative modulators) (Figure 3, green and red
circles) interact either directly or via other proteins (Figure 3
and Table S2A). 31 of the modulators in this network are either
localized exclusively in the nucleus (24 proteins) or shuttle
between the nucleus and cytoplasm (7 proteins). The number
of proteins connected (449) is significantly greater than observed
on average with randomly chosen proteins (80; p < 2.23 1016).
The chromatin modifiers form a central element of the HSR
network, with the EP300/CREBBP histone acetyltransferase
complex interacting directly with SRCAP (Snf2-related CREBBP
activator protein) and via other proteins with HSF1 (Figure 3 and
Table S2A). The connecting proteins between EP300/CREBBP
and HSF1 are mainly histone deacetylases and transcriptional
coactivators. They include TAF12 and TAF5L, subunits of the
PCAF histone acetyltransferase complex, and the histone
methyltransferases RBBP5 (retinoblastoma-binding protein)
and DPY30, which cooperate in methylating lysine 4 on histone
H3, resulting in transcriptional activation. The RBBP5/DPY30
complex connects via other proteins to EP300/CREBBP and
to the E3 ubiquitin protein ligase RBX1, a negative HSR modu-
lator. RBX1 is also connected to EP300/CREBBP and to the
proteasome.
The HSR network includes 63 proteins (Figure 3, blue circles)
that are mainly localized in the nucleus and interact directly
with at least five HSR modulators (Tables S2A and S2B). These
proteins represent potential HSR modulators with functions in
DNA repair, transcriptional regulation, cell-cycle control and
protein degradation via the UPS. In conclusion, the regulation
of the HSR and thus cell survival during stress relies on a com-
plex cooperation of nuclear processes.
Role of Histone Acetyltransferase EP300 in HSF1
Regulation
The chromatin-modifying histone acetyltransferase complex
EP300/CREBBP was identified as a strong positive modulator
of the HSR. EP300 downregulation prevented HSF1-dependent
HSPA1A transcription (Figure S2B), enhanced cytosolic protein
aggregation (Figures 2B and S2A), and reduced cell viability
during HS (Figure S3A). In contrast, EP300 silencing did not inter-
fere with upregulation of ER chaperones (BiP; Grp94) upon tuni-
camycin treatment to induce ER stress (data not shown).
EP300, besides acetylating histones, also modifies several
transcription factors (Caron et al., 2005) and has been reported
to bind to heat shock promoter regions (Westerheide et al.,
2009), suggesting HSF1 as a possible target for acetylation.
Strikingly, downregulation of EP300 in HeLa cells reduced the
steady-state level of HSF1 by 60% (Figure 4A). Note that the
detection of HSF1 by immunoblotting was independent of its
acetylation status (see legend of Figure 4A). In contrast, no
reduction in HSF1 was observed upon silencing of several other
chromatin modifiers that were identified as HSR modulators,
including the closely EP300-related histone acetyltransferase
CREBBP, the histone demethylase KDM3B, or the nucleosome
assembly factor ATRX (Figure S3B). EP300 RNAi neither resulted
in a significant reduction of HSF1 transcript level nor in a general
inhibition of translation (Figures S3C and S3D). Furthermore,
analysis by flow cytometry showed that EP300 downregulation
did not cause cell-cycle arrest (data not shown). Thus, the data
suggest that EP300 alters the level of HSF1 by regulating its turn-
over. EP300 RNAi also reduced the level of HSF1 in HEK293T
cells by 40% (Figure S3E) and accelerated HSF1 degradation,
as observed upon inhibition of translation with cycloheximide
(CHX) (Figures 4B and S3F). Addition of the proteasome inhibitor
MG132 largely prevented the degradation of HSF1 (Figure 4B),
indicating that it occurred via the proteasome. These findings
suggested that acetylation by EP300 conformationally stabilizes
HSF1, possibly by blocking lysine residues for ubiquitylation.
Trimerization of HSF1 upon HS is considered a prerequisite for
chromatin binding (Anckar and Sistonen, 2011). To test whether
EP300 downregulation also affects HSF1 trimerization, we next
monitored the formation of HSF1 oligomers by chemical cross-
linking with ethylene glycol bis(succinimidylsuccinate) (EGS)
(Sarge et al., 1993). HSF1 complexes migrating at 300 kDa
on SDS-PAGE accumulated upon HS and then decayed during
recovery during a period of 1–2 hr (Figure 4C). HSF1 oligomersstill formed when EP300 was downregulated but decayed faster
than in control cells (Figure 4C), which is consistent with altered
conformational properties and reduced activity of HSF1
(Figure S2B).
HSF1 Acetylation
To analyze the acetylation status of HSF1, we expressed GFP-
tagged HSF1 in amino acid isotope-labeled HEK293T cells.
HSF1-GFP was immunoprecipitated from normal and EP300
downregulated cells and acetylation of lysine residues analyzed
by SILAC (stable isotope labeling by amino acids in cell culture)-
based quantitative mass spectrometry (Ong et al., 2002). Note
that endogenous HSF1 could not be analyzed due to its low
abundance (Westerheide et al., 2009). Besides K80 (Wester-
heide et al., 2009), we identified seven additional lysines of
HSF1 to be acetylated, even in the absence of HS, and quantita-
tive data were obtained for K80, K118, K208, K298, and K524
(Figure 4D). Acetylation of K118, K208, and K298 was reduced
in EP300 downregulated cells by 50 % (Figure 4D and Table
S3). K118 acetylation also showed a tendency to increase with
HS. Acetylation of K80 was not reduced upon EP300 silencing
(Figure 4D and Table S3).
We next mutated the EP300-dependent acetylation sites to
glutamine, mimicking acetylation, or to arginine, maintaining
the positive charge, and analyzed the effect of these sub-
stitutions on the ability of HSF1 to form nuclear stress bodies
(nSB) in response to HS. nSB are initiated through interaction
between HSF1 and chromatin at transcription sites of noncoding
satellite III RNA (Biamonti and Vourc’h, 2010) and can be used as
a proxy for HSF1 functionality (Westerheide et al., 2009). EP300
silencing significantly reduced nSB formation by endogenous
HSF1, but not by overexpressed HSF1-GFP (Figure S4A), which
is consistent with a direct role of EP300 in stabilizing the low
abundant endogenous HSF1. As previously reported (Wester-
heide et al., 2009), mutations K80Q and K80R abrogated nSB
formation by HSF1-GFP (Figures 4E and S4B). Interestingly,
we found that mutation K118Q also abolished nSB formation,
whereas K118R formed nSB with similar efficiency to wild-type
HSF1-GFP (Figures 4E and S4B). Thus, a positively charged
residue at position 118 is critical for HSF1 function, and acety-
lation of K118 by EP300 impairs functionality. In contrast, muta-
tion of K208 and K298 to Q or R had no effect on nSB formation
(Figure 4E), suggesting that acetylation of these lysines may
primarily regulate HSF1 turnover. Indeed, mutations K208Q
and K298Q substantially stabilized HSF1-GFP against degrada-
tion in HeLa cells, as measured upon addition of CHX (Fig-
ure S4C). Mutation K208R did not stabilize, indicating that the
reduced turnover of the K208Q mutant is not due to prevention
of ubiquitylation but probably results from the removal of the
positive charge. Mutation K118Q, which causes functional inac-
tivation, also did not stabilize (Figure S4C).
It has been suggested that the deacetylase SIRT1 prolongs
the HSR by deacetylating HSF1 at functionally critical lysines
(Raynes et al., 2013; Westerheide et al., 2009). Indeed, we found
that overexpression of SIRT1 increased the stress-inducible
reporter activity in iFluc-Rluc cells by 2-fold (Figure 4F). Down-
regulation of EP300 completely abolished this effect, indicating
that EP300 functions upstream of SIRT1. Taken together, theseCell 156, 975–985, February 27, 2014 ª2014 Elsevier Inc. 979
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Figure 4. EP300 Functions in Regulating
HSF1 Protein Stability
(A) Decrease in HSF1 level upon silencing of
EP300. HeLa cells were treated with control and
EP300 esiRNA. After 48 hr, cell extracts were
analyzed by SDS-PAGE and immunoblotting with
anti-EP300, anti-HSF1, and anti-GAPDH. Detec-
tion of HSF1 was independent of acetylation
status because the monoclonal anti-HSF1 anti-
body (ab61382; Abcam) recognizes a peptide
comprising residues 378–395. This region con-
tains K391, which was not found to be acetylated
(Westerheide et al., 2009; this study). HSF1 was
quantified by densitometry and was normalized
against corresponding GAPDH levels. SDs are
from at least three independent experiments.
(B) Downregulation of EP300 results in rapid
turnover of HSF1 in HEK293T cells. Cycloheximide
(CHX; 5 mM) with or without MG132 (5 mM) was
added to the cells 48 hr after esiRNA transfection.
After 4 hr at 37C, HSF1 protein level was quanti-
fied by immunoblotting. HSF1 in control cells is set
to 100%. See also Figure S3F. SDs are from at
least three independent experiments.
(C) High-molecular-weight oligomer of HSF1
formed during HS is destabilized upon EP300
downregulation. HeLa cells were transfected with
either control or EP300 esiRNA. After 48 hr, cells
were exposed to HS (2 hr at 43C), followed by
recovery at 37C for the times indicated. Cell
extracts were prepared and subjected to cross-
linking with 1 mM EGS (see Extended Experi-
mental Procedures), followed by immunoblotting
with anti-HSF1. Crosslinked HSF1 oligomers at
300 kDa (dashed rectangle) (Sarge et al., 1993)
were quantified. Amounts present immediately
after HS were set to 100%. SDs from at least three
independent experiments are shown.
(D) HSF1 domain organization indicating the
position of acetylated lysines. DBD, DNA-binding
domain; HR, heptad repeat; RD, regulatory
domain; TAD, transactivation domain. Heat map
shows average SILAC ratios of quantified acety-
lation sites upon EP300 downregulation (48 hr) or
upon HS (1 hr at 43C) relative to control. See
Table S3 for details.
(E) nSB formation by HSF1-GFP mutants. HeLa
cells were transfected with wild-type and mutant
HSF1-GFP and exposed to HS (1 hr at 43C) 24 hr after transfection. The fraction of cells with nSB was quantified. SDs represent results from at least three
different fields of view (100 cells in total).
(F) Overexpression of SIRT1 enhances the HSR by an EP300-dependent mechanism. iFluc-Rluc cells were transfected with control esiRNA targeting EGFP or
esiRNAs targeting EP300, followed after 24 hr by transfection with Flag-SIRT1 when indicated. 20 hr later, cells were exposed to HS for 2 hr at 43C followed by
2 hr recovery at 37C, and reporter activities were measured. SDs are from at least three independent experiments.
See also Figures S3 and S4.findings support a model in which acetylation by EP300 at K208,
K298, and perhaps other lysines conformationally stabilizes
HSF1 for activation, whereas increasing acetylation during HS
at functionally critical lysines, such as K118, attenuates HSF1.
Deacetylation by SIRT1 could oppose this attenuating effect.
Reorganization of the Nuclear Proteome during Heat
Stress
The link between EP300 and HSF1 turnover, along with the
identification of proteasome subunits as negative HSR modula-980 Cell 156, 975–985, February 27, 2014 ª2014 Elsevier Inc.tors, prompted us to explore the role of the proteasome in the
HSR in more detail. We first analyzed changes in the nuclear
proteome of HeLa cells immediately upon HS (2 hr at 43C) or
after recovery (2 hr at 37C) by quantitative proteomics using
SILAC. Note that the nuclear extracts were essentially free of
cytosolic contamination and that both EP300 and HSF1 were
mainly localized in the nucleus (Figures S5A and S5B). We quan-
tified 4,000 proteins, including 36 of the 69 HSR modulators
identified above (Figure 2A) and 212 additional components of
the nuclear HSR network (Figure 3). HS resulted in a significant
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Figure 5. Reorganization of the Nuclear
Proteome during HS and Recovery
(A) Heatmap showing relative enrichment of
proteins in nuclear extracts of HeLa cells during
HS and recovery, as determined by quantitative
proteomics. Color scheme indicates fold enrich-
ment on a Log2 scale.
(B) Cartoon representation of 19S and 20S pro-
teasome subunits describing their relative enrich-
ment in the nuclear fraction upon HS. Color
scheme indicates fold enrichment in the nucleus.
Gray, subunit not identified.
(C) Venn diagram showing the numbers of proteins
in nuclear extracts that were depleted or aggre-
gated during HS (43C for 2 hr) and when HS was
combined with proteasome inhibition (MG132
5 mM). A protein was considered depleted when its
abundance was reduced <0.63-fold in the nuclear
fraction compared to control cells. Proteins
enriched (>1.66-fold) in the insoluble fraction of
total cell extracts were considered as aggregated.
Only aggregated proteins that localize to the nu-
cleus are shown.
(D) Change in abundance of components of the
nuclear HSR regulatory network (Figure 3) during
HS. 44 of the 241 HSR network components
identified in nuclear extracts by proteomics
changed in abundance during HS or recovery
or both. Proteins were considered depleted or
enriched when their abundance in the nuclear
fraction changed <0.63-fold or >1.66-fold,
respectively, compared to control cells. Proteins
shown in red font are HSR modulators identified in
the RNAi screen.
See also Figure S5 and Table S4.accumulation (>1.66- to 17-fold) of a specific set of 32 proteins
in the nucleus (Figure 5A and Table S4A). Among these proteins
are subunits of the 26S proteasome, HSF1, and multiple
chaperones and cochaperones (Figures 5A and 5B). The chaper-
ones include the stress-inducible Hsp70 (HSPA1A and HSPA6)
(Pelham, 1984) and constitutively expressed Hsc70 (HSPA8),
as well as numerous Hsp70 cochaperones (BAG5, DNAJA1,
DNAJA4, DNAJB1, DNAJB4, DNAJC7, ST13, and STIP1) (Fig-
ure 5A and Table S4A).
The accumulation of proteasome subunits and HSF1 in the
nucleus was transient and was reversed during recovery,
whereas many chaperone components remained elevated (Fig-
ure 5A). Interestingly, 34 proteins increased significantly in the
nuclear fraction during recovery (Figure 5A and Table S4B),
including factors involved in nuclear architecture (LMNB2), tran-
scription (FOSL2 and JUN), RNA transport (NXT1), RNA splicing
(SNRPB), and the actin/myosin cytoskeletal machinery.
The chaperones that accumulate in the nucleus upon HS and
the proteasome form a network (Figure S5C), suggesting a func-
tional cooperation in the clearance of stress-denatured proteins.Cell 156, 975–985,Consistent with this interpretation, HS
resulted in an 30%–90% depletion of
237 nuclear proteins (Figure 5C and
Table S4C) without a detectable increaseof these proteins in the cytosolic fraction (data not shown). The
depleted proteins included 7 HSR modulators and 38 compo-
nents of the HSR network (Figure 5D), as well as many nucleolar
and preribosomal proteins (Table S4C). We confirmed that
degradation rather than aggregation was the fate of these
proteins; only 37 of them (25 listed in UniProt) were found to
aggregate substantially, as indicated by a >1.66-fold increase
in the detergent-insoluble fraction of heat-stressed cells (Fig-
ure 5Cand Table S4D). However, aggregation of nuclear proteins
increased strongly when proteasome function was inhibited dur-
ing HS by MG132, and multiple proteasomal subunits were
recovered in the insoluble fraction (Figure 5C and Table S4E).
These results demonstrate that a subset of the nuclear pro-
teome undergoes substantial reorganization during and after
HS, with the proteasome system having a critical role in
removing damaged proteins.
Role of the Proteasome in Attenuation of the HSR
Silencing of individual proteasome components enhanced
Fluc reporter activity in iFluc-Rluc cells upon HS in anFebruary 27, 2014 ª2014 Elsevier Inc. 981
Figure 6. Role of the Proteasome in Attenu-
ating the HSR
(A) Hsp70 mRNA level during HS and recovery
in cells upon silencing of proteasomal subunit
PSMA7. HeLa cells were transfected with esiRNAs
targeting EGFP (control) or PSMA7. 70 hr after
transfection, cells were exposed to HS for 2 hr at
43C, followed by recovery at 37C for up to 24 hr.
HSPA1A (Hsp70) mRNA was analyzed by RT-PCR
and quantified. SDs are from at least three inde-
pendent experiments.
(B) High-molecular-weight oligomer of HSF1
formed during HS is stabilized by proteasome in-
hibition. HeLa cells were exposed to HS as above
and allowed to recover for 2 hr at 37C. MG132
(5 mM) or DMSO was added together with 2 mM
CHX immediately after HS. Cells not exposed to
HS with and without MG132 treatment are shown
as controls. Cell extracts were analyzed by
crosslinking as in Figure 4C. HSF1 oligomers at
300 kDa were quantified with the amount present
immediately after HS set to 100%. SDs are from at
least three independent experiments.
(C) Proteasomal degradation of HSF1 asmeasured
by CHX chase. CHX (5 mM) and 0.1% DMSO or
5 mM MG132 or 10 mM epoxomicin was added to
cells immediately after HS. HSF1 protein level was
analyzed by immunoblotting and quantified. SDs
from at least three independent experiments are
shown. y axis in log scale.
(D) Phosphorylated HSF1 generated upon HS is
degraded. HSF1 immunoblots from CHX chase
experiments as in (C) are shown.
See also Figure S6.HSF1-dependent manner (Figure S6A). Proteasome activity
was inhibited, as judged by the accumulation of GFPu (GFP
fused to a constitutive degradation signal), a protein that is
normally degraded rapidly via the UPS (Figure S6B). Thus, the
accumulation of misfolded proteins resulting from proteasome
inhibition during HS (Figure 5C) might cause the enhancement
of the HSR. However, RNAi against proteasome subunits did
not increase the peak level of Hsp70 mRNA over that reached
during HS alone, but rather delayed its return to control levels
by about 4 hr (Figure 6A), suggesting a role of the proteasome
in attenuating the HSR. Indeed, proteasome inhibition by
MG132 delayed the decay of HSF1 oligomers during recovery
from HS under conditions in which synthesis of new HSF1 was
inhibited by CHX (Figure 6B).
To explore a direct role of the proteasome in HSF1 turnover
after HS, we performed CHX chase experiments in HeLa cells
in the presence and absence of proteasome inhibitors
(MG132 or epoxomicin). After HS, degradation of HSF1 was
accelerated, particularly in the first hour of recovery, reducing
its half-time of decay from 5 hr to 3 hr (Figure 6C). HSF1
was stabilized upon proteasome inhibition (Figure 6C). Thus,
proteasomal degradation of HSF1 occurs with similar kinetics
as the decay of Hsp70 mRNA (Figure 6A). HS resulted in an
upshift of the HSF1 band on SDS-PAGE and immunoblotting982 Cell 156, 975–985, February 27, 2014 ª2014 Elsevier Inc.(Figures 6D and S6C), which is consistent with hyperphos-
phorylation (Holmberg et al., 2001). Treatment of cell extracts
with calf intestinal phosphatase resulted in a change in the
migration pattern of HSF1 both in the presence and absence
of HS (Figure S6C), confirming that the slower migrating
species of HSF1 represents hyperphosphorylated HSF1.
Formation of hyperphosphorylated HSF1 was neither induced
nor inhibited by EP300 downregulation (Figure S6D), suggest-
ing that EP300 maintains HSF1 stability in a phosphorylation-
independent manner. During recovery from HS, activated
HSF1 did not revert to the less phosphorylated species
but was proteasomally degraded, as evident by the stabiliza-
tion of hyperphosphorylated HSF1 upon proteasome inhibition
(Figures 6D and S6C). Attempts to demonstrate ubiquitylation
of endogenous HSF1 during HS by pull-down with His-tagged
ubiquitin were unsuccessful, but when HSF1 was over-
expressed, a ladder of polyubiquitylated HSF1 was observed
upon proteasome inhibition (Figure S6E). The failure to detect
ubiquitylation of endogenous HSF1 may be due to the low
abundance of HSF1 or to efficient competition for ubiquitin
by misfolded proteins. Coupled with the reversibility of ubiqui-
tylation, such competition may ensure that HSF1 remains
active until stress-denatured proteins have been cleared by
the UPS.
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Figure 7. Model of Nuclear Pathways
Involved in HSR Regulation
In the absence of stress, HSF1 is maintained in an
inactive state by chaperones Hsp70 and Hsp90.
This HSF1 is mainly localized in the nucleus. HS
and other forms of protein conformational stress
lead to accumulation of misfolded proteins, which
displace HSF1 from Hsp70/Hsp90. HSF1 oligo-
merizes, undergoes posttranslational modifica-
tions by phosphorylation and acetylation, and
triggers the HSR. Increasing acetylation of HSF1
by EP300 functions as a timer for the induction and
attenuation of the HSR in cooperation with the
deacetylase SIRT1 (and possibly other deacety-
lases). EP300 downregulation results in destabili-
zation of HSF1 and premature degradation by the
proteasome. Activated HSF1 is normally degraded
by the proteasome during the attenuation phase of
the HSR. Ac, acetylation; P, phosphorylation; and
Ub, ubiquitin. See Discussion for details of the
proposed model.Rebinding of HSF1 to Hsp90 has been suggested to play a role
in attenuating the HSR (Bharadwaj et al., 1999; Zou et al., 1998).
We therefore tested whether functional Hsp90 is necessary for
the degradation of activated HSF1. Addition of the specific
Hsp90 inhibitor 17-AAG (17-N-allylamino-17-demethoxygelda-
namycin) immediately after HS had no significant effect on
HSF1 turnover (Figure S6F), although the inhibitor was active
(Figure S6G). Thus, Hsp90 appears not to be critical for protea-
somal degradation of HSF1 after HS.
In summary, during the attenuation phase of the HSR, acti-
vated HSF1 undergoes proteasomal degradation in the nucleus.
As stress-denatured proteins generally compete with HSF1
for ubiquitylation and proteasomal degradation, the extent of
protein damage incurred during stress would control the speed
of HSR attenuation.
DISCUSSION
The cytosolic HSR of mammalian cells integrates positive and
negative signals from multiple cellular processes and locations,
as demonstrated by the RNAi screen reported in this study.
Although most of the identified HSRmodulators exert their func-
tions in the nucleus, we also detected novel regulatory factors in
the cytoplasm, endomembrane system, mitochondria, and the
plasma membrane. Future investigations are likely to reveal
unanticipated mechanisms by which these factors participate
in cell-autonomous and nonautonomous aspects of the HSR.
Role of EP300 in Regulating the HSR
Based on our analysis, HSF1 activation upon HS involves the
function of multiple chromatin modifiers, centering on the
EP300/CREBBP histone acetyltransferase complex. Silencing
of EP300 destabilizes HSF1 in nonstressed cells and induces
its proteasomal degradation (Figure 7, steps 1 and 9). As shown
by quantitative mass spectrometry, EP300 downregulation
results in reduced acetylation of at least three lysines of HSF1
(K118, K208, and K298). Thus, EP300 likely regulates HSF1
directly by acetylation, but effects of EP300 on other factorsmay also play a role. Acetylation of K118 inhibits chromatin
binding of HSF1, i.e., ‘‘deactivating’’ acetylation, as reflected in
the inability of HSF1 mutant K118Q to form nSB. Acetylation of
K80 similarly impairs chromatin binding of HSF1 (Raynes et al.,
2013; Westerheide et al., 2009; this study), and deacetylation
of functionally critical lysines by SIRT1 is suggested to delay
HSF1 attenuation (Raynes et al., 2013; Westerheide et al.,
2009). In contrast, we find that acetylation of K208 and K298
does not correlate with functional impairment of HSF1 in nSB
formation but rather serves to stabilize HSF1 against degrada-
tion, i.e., ‘‘stabilizing’’ acetylation. While acetylation of a lysine
residue prevents ubiquitylation, it may also modulate protein
stability structurally by removing charge repulsion effects (Caron
et al., 2005). Our data suggest that the latter mechanism
predominates for K208 acetylation, as only mutation K208Q,
but not K208R, resulted in stabilization, although both modifica-
tions prevent ubiquitylation. Consistent with a role in attenuation
of the HSR, acetylation of K118 (as tested with mutation K118Q)
does not result in HSF1 stabilization.
Based on these findings, we suggest a model in which
increasing acetylation of HSF1 by EP300 functions as a timing
mechanism regulating activation and attenuation of theHSR (Fig-
ure 7). Initial acetylation at K208, K298, and perhaps additional
lysines stabilizes HSF1 against proteasomal degradation in the
absence of stress and, togetherwith othermodifications, renders
it competent for DNA binding (Figure 7, step 1 and 2). The extent
of acetylation may increase during HS as both HSF1 and EP300
bind to chromatin at heat shock elements (Westerheide et al.,
2009). Eventually, acetylation of functionally critical lysines
such as K118 limits DNA binding capacity and initiates attenua-
tion (Figure 7, steps 3 and 5). SIRT1 acts downstream of EP300
to remove deactivating acetylation, thereby delaying attenuation
(Figure 7, steps 4 and 6), whereas other deacetylases may re-
move stabilizing acetylation to accelerate attenuation (Figure 7,
step 7). Fine-tuning of the HSR may be facilitated by the oligo-
meric nature of active HSF1, with acetylation and deacetylation
occurring on different subunits. Interestingly, a similar mecha-
nism appears to operate in the regulation of the transcriptionCell 156, 975–985, February 27, 2014 ª2014 Elsevier Inc. 983
factor HIF1a. Upon acetylation by EP300, HIF1a is stabilized
against proteasomal degradation (Geng et al., 2012), whereas
hyperacetylation upon silencing of SIRT1 has been shown to
reduce HIF1a transcriptional activity (Laemmle et al., 2012).
Attenuation of the HSR by the Proteasome
Rebinding to chaperones is thought to mediate inactivation of
HSF1 as chaperone capacity is restored during recovery from
stress (Zou et al., 1998) (Figure 7, step 8). Our observation that
activated (i.e., hyperphosphorylated) HSF1 is degraded by the
proteasome suggests an alternative (or parallel) mechanism for
attenuation of the HSR (Figure 7, step 7). An important element
of this mechanism is the coupling of HSR attenuation with clear-
ance of misfolded proteins by the proteasome. The nuclear pro-
teome is sensitive to different forms of stress (Boulon et al.,
2010). We find that many nuclear proteins are damaged during
HS and must be degraded in a proteasome-dependent manner,
explaining the transient accumulation of proteasome and chap-
erone components in the nucleus upon HS. The misfolded
proteins generated during stress would compete with HSF1 for
ubiquitylation and proteasomal degradation, thereby delaying
attenuation of the HSR until clearance of damaged proteins
has been accomplished. Thus, attenuation of the stress
response is directly linked with recovery of proteome balance.
It may be inferred from these considerations that the increase
of protein misfolding associated with cellular aging and neuro-
degenerative diseases would result in chronic stress and dereg-
ulation of the HSR by overwhelming proteasome capacity.
EXPERIMENTAL PROCEDURES
Cell Culture and Transfection
HeLa and HEK293T cells were cultured under standard conditions (see
Extended Experimental Procedures). Transfection was performed with Lipo-
fectamine and PLUS reagent (Invitrogen). esiRNA reverse-transfection exper-
iments were performed with Lipofectamine RNAiMAX (Invitrogen). The stable
reporter cell line expressing Fluc and Rluc (iFluc-Rluc) used in the screen
and the reporter cell line stably expressing FlucDM-GFP (Gupta et al., 2011)
were generated by standard methods.
Genome-Scale RNA Interference Screen
The esiRNA library was designed and synthesized as described (Kittler et al.,
2005, 2007). Screen experiments were performed in 384 well format using a
robotics system. Dual-Glo luciferase reagent (Promega) was used to measure
Fluc and Rluc activities. A detailed screening protocol and the analysis of
screen results are described in the Extended Experimental Procedures.
Fluorescence Microscopy
Fluorescence imaging was performed on a Zeiss Axiovert 200M fluorescence
microscope equipped with a Zeiss Axiocam HRM camera and images
analyzed using Axiovision Rel 4.7 software.
SILAC Labeling and Liquid Chromatography-Tandem Mass
Spectrometry Analysis
SILAC labeling of HeLa and HEK293T cells was performed in custom medium
supplemented with light, medium, or heavy arginine and lysine isotopes (see
the Extended Experimental Procedures).
Nuclear fractions were prepared using the NE-PER Nuclear and Cyto-
plasmic Extraction Kit (Thermo Scientific). To prepare detergent insoluble
fractions containing aggregated proteins, cells were lysed in RIPA lysis buffer,
cell lysates were centrifuged (30min at 14,0003 g), and pellets were dissolved
in SDS lysis buffer. Sample preparation for liquid chromatography-tandem984 Cell 156, 975–985, February 27, 2014 ª2014 Elsevier Inc.mass spectrometry (LC-MS/MS) is described in detail in the Extended Exper-
imental Procedures. Protein identification and SILAC based quantitation was
performed using MaxQuant (version 1.1.1.36).
Miscellaneous Methods
Flow cytometry, immunoblotting and antibodies used (Table S5), RT assays
and the PCR primers used (Table S6), radiolabeling of cells, chemical cross-
linking of HSF1, and computational and bioinformatic data analysis are
described in the Extended Experimental Procedures.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures, six
figures, and six tables and can be found with this article online at http://dx.
doi.org/10.1016/j.cell.2014.01.055.
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